DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

Anterior uveitis

Essential points for quick revision.

!
Painful photophobic red eye

Anterior uveitis can threaten vision and cannot be confirmed from redness alone; microbial keratitis and other ocular emergencies may look similar.

Action: Arrange urgent ophthalmic assessment, usually within 24 hours, and use same-day emergency assessment for marked visual loss, severe pain, a hypopyon or diagnostic concern for infection. Do not start an ocular steroid before the eye has been appropriately examined.

Synopsis

Recognise inflammation of the iris and anterior uveal tract, arrange prompt ophthalmic confirmation, and understand supervised treatment, targeted investigation and surveillance for visual complications.

  • Anterior uveitis involves inflammation at the front of the uveal tract, commonly producing aching pain, photophobia, redness and blurred vision.
  • Slit-lamp evidence of anterior chamber cells and flare supports the diagnosis and allows activity to be monitored.
  • Ciliary injection and a small or irregular pupil are useful clues, but their absence does not exclude inflammation.

Key red flags

New visual reduction, severe pain, a hypopyon or rapidly progressive redness requires same-day emergency assessment.

Investigation priorities

01
Visual acuity and slit-lamp examinationFirst step

Confirm anterior inflammation and document its effect on function.

Management branches

Suspected episodeObtain prompt ophthalmic confirmation

Pain, photophobia, ciliary redness or visual disturbance raises concern for anterior uveitis.

  1. Document acuity and relevant history, including contact lenses, ocular procedures, prior uveitis and any systemic illness.
  2. Arrange ophthalmic assessment urgently, generally within 24 hours, with immediate escalation for severe findings or possible infection.

Key medicines

Prednisolone acetate 1% eye drops, Pred ForteThe adult SmPC describes one to two drops into the affected eye two to four times daily; during the initial 24 to 48 hours this may be increased to two drops hourly. Ophthalmology individualises intensity, duration and taper to the examined inflammatory activity.
Cyclopentolate 1% eye drops, MinimsFor adult uveitis and posterior synechiae, the SmPC describes one to two drops every six to eight hours, with strength adjusted to clinical response. Ophthalmology determines the treatment period and review.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom